1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Geriatric Medicines Market

Geriatric Medicines Sector Analysis, Projection in the coming years

  • February 2016
  • 86 pages
  • ID: 3999550
In this report:
In 2010 approximately ##-##% of the prescriptions were provided to people aged ## and above and one in three patients took at least ## drugs or more on a daily basis in United States.
According to the Eurostat the number of people aged ## tears and above is likely to be ## million by 2050 globally which is approximately ##%-##% increase in specific population group as compared to 2008 geriatric population.


Table of Contents

This study on the geriatrics medicines market studies the current and future prospects of the overall market. Geriatrics is a branch of medicines concerned with clinical, remedial, preventive, and social aspects of illness usually among people over 65 years of age. In response to the needs and demands of an aging population, demand for geriatric medicines has grown quickly in last few decades. The elderly patients across the world face an array of ill health conditions which include co-morbid complexities including falls, cerebral ageing, and syncope among others. According to the Eurostat the number of people aged 65 tears and above is likely to be 141 million by 2050 globally which is approximately 17%-30% increase in particular population group as compared to 2008 geriatric population. An article published by the Indian Express in June 2014 stated that people aged 60 years and above are likely to reach 323 million mark by 2050. In 2010 approximately 45 - 50.0 percent of the prescriptions were provided to people aged 60 and above and one in three patients took at least 5 drugs or more on a daily basis in United States. In last few decades, geriatric medicines have experienced substantial growth due to which it has now become a main part of the American medicines. National Institute on Aging aims to improve health and well-being of older Americans through research and identification of additional clinical interventions. In general geriatric medicines market can be split in three important sub classes' namely therapeutic category, condition, and territory.

This analysis offers detailed analysis of the overall geriatric medicines market. The stakeholders for this market report contain firms engaged in the industry research and development, manufacturing and commercialization of geriatric medicines, providers, and new sector entrants planning to invest in this sector. For providing a snapshot of this market to the stakeholders, executive summary section is included in this business report, which summarizes the market value, forecasts, and competition for distinct geriatric medicines in the main five regions.

This research study examines the industry for geriatric medicine market in terms of income. For the industry research, 2014 has been considered as the base year, while all forecasts have been provided from 2015 to 2023. The overall geriatric medicine market has been mostly divided based on condition (Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis, Respiratory and Others), therapeutic category (Analgesic, Antihypertensive, Statins, Antidiabetic, Proton Pump Inhibitor, Anticoagulant, Antipsychotic, antidepressant and others), and area (North America continent, Europe (EU), Asia Pacific (APAC), Latin America area, and Middle East (ME) & African continent).

The market overview section of this report examines market dynamics including drivers, market restraints, and alternatives that impact the geriatric medicines market in the current and future scenario. Moreover, the Analysis of market appeal and pipeline analysis has been included in market overview section in order to explain the intensity of competition in the sector. Challenging scenario among the key market players is analyzed through a heat map of main market players in the ambitious landscape section of the report. All these aspects will help the key market players to decide about the business strategies and plans to be incurred in future for strengthening their position in the overall market.

Main drivers that will positively uplift and boost the industry demand and increase for geriatric medicines market contain growing trend with respect to electric record among physicians which reduces the patient discomfort and helps practitioners having continuous patient monitoring. Apart from this innovations associated to multiple chronic disease treatment, rising collaboration of lay organization and NGOs with professional group will drive the geriatric medicines market in coming years. Some of the main restraints to this market contain lack of patient participation in clinical trials leading to development of vaccines or drugs that are not completely studied and safe.

This industry report also comprises recommendations section that will assist additional companies in establishing their presence and industry actors in expanding their market share in the geriatric medicines market. The market research closes with the company profile section which comprises company overview, financial review, product portfolio, strategic management, and recent evolutions for market actors. Some of the main players in geriatric medicines market contain Abbott Laboratories, Incorporated, AstraZeneca plc, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Organization, GlaxoSmithKline Plc., Merck & Company Inc., Novartis AG, Pfizer, Incorporated, Sanofi S.A

The overall geriatric medicines segment is split as follows:

Overall Geriatric Medicines Market, by Therapeutic Category

Overall Geriatric Medicines Market, by Condition

Overall Geriatric Medicines Market, by Geography

North America (NA)


Canada (CA)

Europe (EU)

Germany (DE)

France (FR)

Rest of europe (EU)


China (CN)

Japan (JP)

Rest of Asia Pacific (APAC)

Latin America

Brazil (BR)

Rest of LATAM

Middle East and Africa

South africa (SA)

Rest of middle east and African regions (MEA)

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Veterinary Pain Management Market by Product, Application, Animal Type, Distribution Channel - Global Forecast to 2023

Veterinary Pain Management Market: Global Forecast until 2023

  • $ 5650
  • Industry report
  • April 2018
  • by MarketsandMarkets

Global veterinary pain management market projected to grow at a CAGR of 8.0%The global veterinary pain management market is projected to reach USD 1.66 billion by 2023 from USD 1.13 billion in 2018, at ...

Cold Pain Therapy Market by Product, Prescription-Based, Applications - Global Forecast to 2023

Cold Pain Therapy Market: Global Forecast until 2023

  • $ 5650
  • Industry report
  • June 2018
  • by MarketsandMarkets

The cold pain therapy market is projected to grow at a CAGR of 4.6%.The global cold pain therapy market is projected to reach USD 2.12 billion by 2023 from USD 1.69 billion in 2018, at a CAGR of 4.6%. ...

Global Oligonucleotide Therapeutics Market 2018-2022

Oligonucleotide Therapeutics Sector: Worldwide Forecast until 2022

  • $ 2500
  • Industry report
  • June 2018
  • by Infiniti Research Limited

About Oligonucleotide TherapeuticsOligonucleotides are short nucleotides sequences of DNA or RNA molecules called oligomers. Oligonucleotide therapeutics target and inhibit the expression of certain d ...


Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on